Does BIMEKIZUMAB-BKZX Cause Condition aggravated? 115 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Condition aggravated have been filed in association with BIMEKIZUMAB-BKZX. This represents 2.2% of all adverse event reports for BIMEKIZUMAB-BKZX.
115
Reports of Condition aggravated with BIMEKIZUMAB-BKZX
2.2%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
9
Hospitalizations
How Dangerous Is Condition aggravated From BIMEKIZUMAB-BKZX?
Of the 115 reports, 9 (7.8%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Psoriasis (621)
Drug ineffective (402)
Product availability issue (364)
Off label use (335)
Psoriatic arthropathy (301)
Injection site pain (263)
Therapy interrupted (252)
Hidradenitis (233)
Inappropriate schedule of product administration (214)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Condition aggravated Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES